alexa The Impact of Serum Interleukin-17 on Chronic Hepatitis C and Its Sequelae

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

The Impact of Serum Interleukin-17 on Chronic Hepatitis C and Its Sequelae

Recently, interleukin-17 (IL-17) cytokine family plays important roles in the host immunity in chronic inflammatory conditions, autoimmune and viral liver diseases. However, studies on the IL-17 role in the immunopathogenesis of hepatitis C virus (HCV) infection are limited. Objectives: to assess serum IL-17 levels in chronically HCV infected patients and their relations to the severity of liver disease. Patients and methods: The study included 200 chronically HCV infected patients; 100 chronic hepatitis C, 100 liver cirrhosis including 35 with hepatocellular carcinoma (HCC) and 30 controls. Serum IL-17 levels were quantified by ELISA. Results: Serum IL-17 levels were significantly higher in chronically HCV infected patients than controls and cirrhotics had the highest levels (P<0.001). These levels were positively related with inflammation grade and fibrosis stage. Serum IL-17 was significantly higher in HCC than controls. IL-17 was significantly correlated with prothrombin time, ALT, serum albumin, viral load, and alpha fetoprotein-L3. Conclusion: IL-17 levels were increased with increasing liver disease progression and chronicity. Thus, IL-17 may be an important biological marker for the immunopathogenesis of chronic hepatitis, liver fibrosis and HCC.

 

Hassan EA, Abd El-Rehim ASE, Ahmed AO, Elsherbiny NM, Abo Elhagag NAE (2014) The Impact of Serum Interleukin-17 on Chronic Hepatitis C and Its Sequelae. J Liver 3:163

 
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
 
adwords